Rumors had been circulating for months, and for several weeks now, talk among industry insiders had become increasingly frequent, but there had never been an official announcement or confirmation. Even we, as the Italian base for F Italiana Genova, knew something was up but had never received an official communication. Now it is official: Italian Pharmacy Genoa, an Italian leader in the testing and production of sports medicines and PEDs, has acquired a majority stake in the group Kuwait Pharma Labs, the UGL’s major laboratory in the Middle East.
Negotiations between Kuwait Pharma and Farmacia Italiana Genova
For years, Kuwait Pharma Labs has been at the forefront of the industry thanks to its ties with Oxygen Gym and its professional sports team in Kuwait. This team has produced great bodybuilding champions for years, including Roelly Winklaar and 2019 Mr. Olympia Brandon Curry, and has launched immense talents such as the current two-time Mr. Olympia, Big Ramy. For years, there has been speculation about how these talents burst onto the scene and became unbeatable champions, turning Kuwait into a notable bodybuilding hub. During that period, when the possession of anabolic steroids was legal in Kuwait, Kuwait Pharma Labs was the leading supplier and a main manufacturer of steroids for Kuwait and its sports teams.
In 2020, just before the pandemic, Kuwait tightened its laws against the proliferation of PEDs and anabolic steroids, forcing Kuwait Pharma to shift its focus to the European market. Italian Pharmacy Genoa, thanks to its network of sports teams around the world, was the first official distributor of Kuwait Pharma products in Europe. We at Steroidi Anabolizzanti Italia were, in fact, the first to distribute them in Europe, with strong success and appreciation from our customers.
Unfortunately for KP, the European market is not as straightforward as the Middle Eastern market, especially if you are not based in the EU. Direct sales by Kuwait Pharma through their website and sales representatives were not high enough to justify such a large laboratory with several professional employees. The only solution was to close or sell the business, specifically the European part. After lengthy negotiations lasting almost a year, it is now official that Farmacia Italiana Genova has acquired more than 80% of Kuwait Pharma Labs, including laboratory equipment, staff, warehouse, and the entire catalog.
Changes following the acquisition
The transition will not be immediate. Kuwait Pharma will continue to operate, at least for now, under the Kuwait Pharma Labs brand, even though it will be a full-fledged part of the F Italiana Genova group with its tax domicile in the Netherlands and laboratories in Europe. This fact will also be highlighted in the future on product labels and in marketing materials. The first official step is expected at the end of October, when customers shopping on kuwaitpharma.com will be paying Farmacia Italiana directly. The KP website has already announced the change in ownership.
For you, our customers, the difference will be minimal. Little or nothing will change except that the quality of the Kuwait Pharma brand will improve thanks to the know-how of Farmacia Italiana Genova.
Check back for further updates on kuwaitpharma.com.
